Significant Ownership of Stonepine Capital Management, LLC

Signature - Title
/s/ Jon M. Plexico - Managing Member
Location
Bend, OR
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Stonepine Capital Management, LLC.

Notify me when Stonepine Capital Management, LLC files a new Schedule 13D/G report.

⭐ Subscribe ⭐

Significant Ownership of Stonepine Capital Management, LLC

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
QNRX Quoin Pharmaceuticals, Ltd. Ordinary Shares 9.9% $62,800,787 3,030,926 Stonepine Capital Management, LLC 10 Dec 2025
AYTU AYTU BIOPHARMA, INC Common Stock 9.9% $2,093,006 906,063 Stonepine Capital Management, LLC 30 Jun 2025
INAB IN8BIO, Inc. Common Stock 9.9% $1,693,423 1,007,990 Stonepine Capital Management, LLC 19 Dec 2025
EDSA Edesa Biotech, Inc. Common Stock 9.9% $1,595,167 693,551 Stonepine Capital Management, LLC 13 Feb 2025
OPTN OptiNose, Inc. Common Stock 7.8% $7,097,823 +$1,799,910 788,647 +34% Stonepine Capital Management, LLC 31 Mar 2025
TELA TELA Bio, Inc. Common Stock 6% $2,423,692 2,353,099 Stonepine Capital Management, LLC 31 Dec 2024
SRZN Surrozen, Inc./DE Common Stock 5.8% $5,941,464 +$2,058,436 508,687 +53% Stonepine Capital Management, LLC 30 Jun 2025
CNSP CNS Pharmaceuticals, Inc. Common Stock 5.6% $289,980 32,220 Stonepine Capital Management, LLC 29 Oct 2025
KZR Kezar Life Sciences, Inc. Common Stock 5.2% $1,493,870 377,240 Stonepine Capital Management, LLC 02 Sep 2025
CALC CalciMedica, Inc. Common Stock 4.6% $993,302 -$178,586 628,672 -15% Stonepine Capital Management, LLC 31 Mar 2025
VSTM Verastem, Inc. Common Stock 4.3% $23,583,859 -$1,442,405 2,670,032 -5.8% Stonepine Capital Management, LLC 30 Sep 2025
APRE Aprea Therapeutics, Inc. Common Stock 4.3% $488,409 -$95,837 239,416 -16% Stonepine Capital Management, LLC 31 Mar 2025
INO Inovio Pharmaceuticals, Inc. Common Stock 3.8% $2,310,345 -$775,487 1,434,997 -25% Stonepine Capital Management, LLC 31 Mar 2025

Schedules 13D/G Reported by Stonepine Capital Management, LLC:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Filing Date
* An asterisk sign (*) next to the price indicates that the price is likely invalid.